Rapidly Screen Lab Science
for Commercial Viability!
SynapseMed mines publications, patents, clinical trials, and institutional research signals to surface commercially valuable biomedical opportunities before they are obvious.
Built for technology transfer teams and investors who need faster signal from complex biomedical research.
Introducing SynapseMed
by Circee Health!
SynapseMed turns scattered biomedical evidence into practical, commercial intelligence.
A shorter path from research signal to licensing, partnership, or investment conversation.
Ingest
Publications, patent signals, clinical trials, and institution-linked research activity.
Prioritize
Cluster signals into opportunity areas and rank them for commercial relevance.
Translate
Create decision-ready briefs with market, regulatory, reimbursement, and buyer context.
For Technology Transfer Offices
Find commercially promising innovations already hiding inside your institution’s publications, patents, and clinical trial activity.
More licensing-ready opportunities without waiting for disclosures!
For VCs and Strategic Investors
See emerging biomedical opportunities before they become obvious, crowded, or already priced into the market.
Want an early signal layer for research-driven deal flow?
Commercialization and TTO Operations Support
Circee Health is not only a discovery company, we also help institutions build and use secure, in-house AI workhorses to reduce your workload and turn promising research signals into practical commercialization workflows, stronger licensing conversations, and clearer operating models for technology transfer teams.
VC Consulting
- Opportunity assessment and prioritization
- Commercial thesis development
- Research market, competitor, regulatory, and reimbursement
- Strategic buyer and partner mapping
- Investor- and licensee-ready opportunity briefs
TTO Operations Consulting
- Prioritize technology portfolios
- Deploy “shrink-wrap” licensing
- Templatize legal and deal terms
- Surface high-probability licensing paths
- Discover strategic buyers early
- Align internal workflows with marketing
Research Output
Publications • Patents • Trials
Publications • Patents • Trials
→
Opportunity Signal
Clusters • Fit • Strength
Clusters • Fit • Strength
→
Commercial Action
Briefs • Buyers • Next Steps
Briefs • Buyers • Next Steps
The result: fewer scattered signals, better prioritization, and a clearer path from research evidence to licensing or venture interest.
